background brugada syndrome inherited disease associated sudden cardiac death electrocardiographic pattern associated brugada syndrome linked use sodium channel blockers including antiarrhythmics trycyclics anesthetics objective report case brugada syndrome investigated genetic biophysical path physiological mechanism involved methods results patient developed electrocardiographic pattern twice influence bupivacaine occurrence accompanied ventricular tachycardia vt subsided withdrawal anesthetic vt observed diltiazem agents thought facilitate st segment elevation brugada syndrome genetic analysis revealed missense mutation alpha subunit cardiac sodium channel scn5a biophysical analysis patchclamping revealed reduction sodium current result mutation study bupivacaine wedge model revealed changes conduction heterogeneous loss action potential dome rv epicardium phase NUMBER preparations pretreated low concentrations calcium channel blocker verapamil conclusion findings indicate bupivacaine induce electrocardiographic arrhythmic manifestations brugada syndrome silent carriers scn5a mutations data important implications management patients develop st segment elevation influence anesthetics bupivacaine bupivacaine induced brugada like administration isosorbide NUMBER mononitrate cell use dependent entry